• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

脂联素通过AdipoR1/LKB1/AMPK依赖性途径抑制肝脏中SREBP1c的表达。

Adiponectin suppresses hepatic SREBP1c expression in an AdipoR1/LKB1/AMPK dependent pathway.

作者信息

Awazawa Motoharu, Ueki Kohjiro, Inabe Kazunori, Yamauchi Toshimasa, Kaneko Kazuma, Okazaki Yukiko, Bardeesy Nabeel, Ohnishi Shin, Nagai Ryozo, Kadowaki Takashi

机构信息

Department of Metabolic Diseases, Graduate School of Medicine, University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, Tokyo 113-8655, Japan.

出版信息

Biochem Biophys Res Commun. 2009 Apr 24;382(1):51-6. doi: 10.1016/j.bbrc.2009.02.131. Epub 2009 Feb 28.

DOI:10.1016/j.bbrc.2009.02.131
PMID:19254698
Abstract

Adiponectin, one of the insulin-sensitizing adipokines, has been shown to activate fatty acid oxidation in liver and skeletal muscle, thus maintaining insulin sensitivity. However, the precise roles of adiponectin in fatty acid synthesis are poorly understood. Here we show that adiponectin administration acutely suppresses expression of sterol regulatory element-binding protein (SREBP) 1c, the master regulator which controls and upregulates the enzymes involved in fatty acid synthesis, in the liver of +Lepr(db)/+Lepr(db) (db/db) mouse as well as in cultured hepatocytes. We also show that adiponectin suppresses SREBP1c by AdipoR1, one of the functional receptors for adiponetin, and furthermore that suppressing either AMP-activated protein kinase (AMPK) via its upstream kinase LKB1 deletion cancels the negative effect of adiponectin on SREBP1c expression. These data show that adiponectin suppresses SREBP1c through the AdipoR1/LKB1/AMPK pathway, and suggest a possible role for adiponectin in the regulation of hepatic fatty acid synthesis.

摘要

脂联素是一种具有胰岛素增敏作用的脂肪因子,已被证明可激活肝脏和骨骼肌中的脂肪酸氧化,从而维持胰岛素敏感性。然而,脂联素在脂肪酸合成中的具体作用尚不清楚。在此我们表明,给予脂联素可急性抑制 +Lepr(db)/+Lepr(db)(db/db)小鼠肝脏以及培养的肝细胞中固醇调节元件结合蛋白(SREBP)1c的表达,SREBP 1c是控制和上调参与脂肪酸合成的酶的主要调节因子。我们还表明,脂联素通过其功能性受体之一AdipoR1抑制SREBP1c,此外,通过其上游激酶LKB1缺失抑制AMP激活的蛋白激酶(AMPK)可消除脂联素对SREBP1c表达的负面影响。这些数据表明脂联素通过AdipoR1/LKB1/AMPK途径抑制SREBP1c,并提示脂联素在肝脏脂肪酸合成调节中可能发挥作用。

相似文献

1
Adiponectin suppresses hepatic SREBP1c expression in an AdipoR1/LKB1/AMPK dependent pathway.脂联素通过AdipoR1/LKB1/AMPK依赖性途径抑制肝脏中SREBP1c的表达。
Biochem Biophys Res Commun. 2009 Apr 24;382(1):51-6. doi: 10.1016/j.bbrc.2009.02.131. Epub 2009 Feb 28.
2
SREBP-1c, regulated by the insulin and AMPK signaling pathways, plays a role in nonalcoholic fatty liver disease.受胰岛素和AMPK信号通路调控的SREBP-1c在非酒精性脂肪性肝病中发挥作用。
Int J Mol Med. 2008 Apr;21(4):507-11.
3
Regulation of synthesis and oxidation of fatty acids by adiponectin receptors (AdipoR1/R2) and insulin receptor substrate isoforms (IRS-1/-2) of the liver in a nonalcoholic steatohepatitis animal model.脂联素受体(AdipoR1/R2)和肝胰岛素受体底物同工型(IRS-1/-2)对非酒精性脂肪性肝炎动物模型中脂肪酸合成和氧化的调节。
Metabolism. 2011 Jun;60(6):805-14. doi: 10.1016/j.metabol.2010.07.032. Epub 2010 Sep 16.
4
Adiponectin activates the AMPK signaling pathway to regulate lipid metabolism in bovine hepatocytes.脂联素通过激活 AMPK 信号通路调节牛肝细胞的脂代谢。
J Steroid Biochem Mol Biol. 2013 Nov;138:445-54. doi: 10.1016/j.jsbmb.2013.08.013. Epub 2013 Aug 30.
5
Adiponectin increases fatty acid oxidation in skeletal muscle cells by sequential activation of AMP-activated protein kinase, p38 mitogen-activated protein kinase, and peroxisome proliferator-activated receptor alpha.脂联素通过依次激活AMP活化蛋白激酶、p38丝裂原活化蛋白激酶和过氧化物酶体增殖物激活受体α来增加骨骼肌细胞中的脂肪酸氧化。
Diabetes. 2006 Sep;55(9):2562-70. doi: 10.2337/db05-1322.
6
Hyperglycemia- and hyperinsulinemia-induced alteration of adiponectin receptor expression and adiponectin effects in L6 myoblasts.高血糖和高胰岛素血症诱导的脂联素受体表达改变及脂联素对L6成肌细胞的影响
J Mol Endocrinol. 2005 Dec;35(3):465-76. doi: 10.1677/jme.1.01877.
7
LKB1 and the regulation of malonyl-CoA and fatty acid oxidation in muscle.LKB1与肌肉中丙二酰辅酶A及脂肪酸氧化的调节
Am J Physiol Endocrinol Metab. 2007 Dec;293(6):E1572-9. doi: 10.1152/ajpendo.00371.2007. Epub 2007 Oct 9.
8
Impaired adiponectin-AMPK signalling in insulin-sensitive tissues of hypertensive rats.高血压大鼠胰岛素敏感组织中脂联素-AMPK信号传导受损。
Life Sci. 2008 Oct 10;83(15-16):540-9. doi: 10.1016/j.lfs.2008.07.022. Epub 2008 Aug 14.
9
LKB1, an upstream AMPK kinase, regulates glucose and lipid metabolism in cultured liver and muscle cells.LKB1是一种上游AMPK激酶,可调节培养的肝细胞和肌肉细胞中的葡萄糖和脂质代谢。
Biochem Biophys Res Commun. 2006 Dec 22;351(3):595-601. doi: 10.1016/j.bbrc.2006.10.056. Epub 2006 Oct 18.
10
S-adenosylmethionine attenuates hepatic lipid synthesis in micropigs fed ethanol with a folate-deficient diet.S-腺苷甲硫氨酸可减轻用叶酸缺乏饮食喂养乙醇的小型猪的肝脏脂质合成。
Alcohol Clin Exp Res. 2007 Jul;31(7):1231-9. doi: 10.1111/j.1530-0277.2007.00407.x.

引用本文的文献

1
Inter-organ metabolic interaction networks in non-alcoholic fatty liver disease.非酒精性脂肪性肝病中的器官间代谢相互作用网络。
Front Endocrinol (Lausanne). 2025 Jan 9;15:1494560. doi: 10.3389/fendo.2024.1494560. eCollection 2024.
2
The effect and application of adiponectin in hepatic fibrosis.脂联素在肝纤维化中的作用及应用
Gastroenterol Rep (Oxf). 2024 Dec 30;12:goae108. doi: 10.1093/gastro/goae108. eCollection 2024.
3
New Insights into AMPK, as a Potential Therapeutic Target in Metabolic Dysfunction-Associated Steatotic Liver Disease and Hepatic Fibrosis.
AMPK作为代谢功能障碍相关脂肪性肝病和肝纤维化潜在治疗靶点的新见解
Biomol Ther (Seoul). 2025 Jan 1;33(1):18-38. doi: 10.4062/biomolther.2024.188. Epub 2024 Dec 20.
4
GR113808, a serotonin receptor 4 antagonist, prevents high-fat-diet-induced obesity, fatty liver formation, and insulin resistance in C57BL/6J mice.GR113808,一种 5-羟色胺受体 4 拮抗剂,可预防 C57BL/6J 小鼠的高脂肪饮食诱导的肥胖、脂肪肝形成和胰岛素抵抗。
BMC Pharmacol Toxicol. 2024 Oct 11;25(1):76. doi: 10.1186/s40360-024-00800-3.
5
Identification of genomic regions associated with fatty acid metabolism across blood, liver, backfat and muscle in pigs.鉴定与猪血液、肝脏、背膘和肌肉中脂肪酸代谢相关的基因组区域。
Genet Sel Evol. 2024 Sep 26;56(1):66. doi: 10.1186/s12711-024-00933-3.
6
Recent Advances in Pre-Clinical Development of Adiponectin Receptor Agonist Therapies for Duchenne Muscular Dystrophy.用于杜兴氏肌营养不良症的脂联素受体激动剂疗法的临床前开发的最新进展
Biomedicines. 2024 Jun 25;12(7):1407. doi: 10.3390/biomedicines12071407.
7
Cornelian Cherry ( L.) Fruit Extract Lowers SREBP-1c and C/EBPα in Liver and Alters Various PPAR-α, PPAR-γ, LXR-α Target Genes in Cholesterol-Rich Diet Rabbit Model.Cornelian Cherry ( L.) Fruit Extract 降低肝脏中 SREBP-1c 和 C/EBPα,并改变富含胆固醇饮食兔模型中各种 PPAR-α、PPAR-γ、LXR-α 的靶基因。
Int J Mol Sci. 2024 Jan 18;25(2):1199. doi: 10.3390/ijms25021199.
8
Metformin Inefficiency to Lower Lipids in Vitamin B12 Deficient HepG2 Cells Is Alleviated via Adiponectin-AMPK Axis.维生素 B12 缺乏的 HepG2 细胞中二甲双胍降低脂质的效率通过脂联素-AMPK 轴得到改善。
Nutrients. 2023 Dec 8;15(24):5046. doi: 10.3390/nu15245046.
9
Inter-organ crosstalk during development and progression of type 2 diabetes mellitus.2型糖尿病发生发展过程中的器官间串扰。
Nat Rev Endocrinol. 2024 Jan;20(1):27-49. doi: 10.1038/s41574-023-00898-1. Epub 2023 Oct 16.
10
Adiponectin: friend or foe in obesity and inflammation.脂联素:肥胖与炎症中的朋友还是敌人?
Med Rev (2021). 2022 Jul 1;2(4):349-362. doi: 10.1515/mr-2022-0002. eCollection 2022 Aug.